Martin Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$6.53M |
| 2 |
Adobe
ADBE
|
+$6.34M |
| 3 |
Wabtec
WAB
|
+$5.95M |
| 4 |
Haleon
HLN
|
+$304K |
| 5 |
Icon
ICLR
|
+$191K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$6.78M |
| 2 |
Carrier Global
CARR
|
+$6.11M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$5.7M |
| 4 |
RTX Corp
RTX
|
+$3.58M |
| 5 |
FMC
FMC
|
+$3.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.62% |
| 2 | Healthcare | 28.68% |
| 3 | Financials | 11.03% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 9.65% |
Similar funds
Martin Investment Management's Q4 2023 Portfolio in Review
As of Q4 2023, Martin Investment Management held 53 positions worth $336M, up 0.58% from $334M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Martin Investment Management withdrew a net $22.7M in Q4 2023, closing 5 positions and reducing 32 holdings. Its most notable exit was Johnson & Johnson, an estimated $6.78M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Martin Investment Management opened a new position in Ametek worth $7.07M.
- Martin Investment Management's largest Q4 2023 buy was Ametek: 42,857 shares worth $7.07M.
- Martin Investment Management added most to Medtronic in Q4 2023, an estimated $76.1K increase.
- Martin Investment Management's biggest Q4 2023 reduction was Bristol-Myers Squibb, cutting an estimated $5.7M.
- Martin Investment Management fully exited Johnson & Johnson in Q4 2023, selling an estimated $6.78M.
- Martin Investment Management's ten largest holdings make up 59% of its $336M portfolio in Q4 2023.
- Martin Investment Management opened 5 new positions and closed 5 in Q4 2023.
- Martin Investment Management's portfolio value rose 0.58% quarter-over-quarter to $336M.
Based on Martin Investment Management's 13F filing for Q4 2023, filed 6 Feb 2024.